Liankang Bioscience Technology Group (00690.HK) grants 300 million share purchase rights

Zhichong Finance News App, Linkon Biotechnology Group (00690.HK) announced that on June 24, 2026, the company has granted stock options to four eligible participants (subject to their acceptance) under the stock option plan, to subscribe for a total of 300 million shares (after all are exercised and may be adjusted according to the stock option plan).